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ABSTRACT
Introduction: Gastroesophageal reflux disease (GERD) is a multifactorial disease 
associated with environmental and genetic factors. Obesity is among the risk factors 
for its development, which also correlates with an increase in severity of clinical 
presentation and a higher incidence of complications associated with reflux.
Methods: This historical cohort study included a sample of 249 patients who had 
undergone bariatric surgery using the Roux-en-Y gastric bypass technique at the 
Hospital São Vicente de Paulo, Passo Fundo, southern Brazil, from January 2014 
to December 2015.
Results: Of 249 patients, 77.9% (190 patients) were female and the mean age was 
38 years. The occurrence of reflux esophagitis was 81.1% (196 patients) in the preoperative 
period and 31.3% (75 patients) in the postoperative period. With regard to bariatric 
treatment response to control moderate and severe esophagitis (grades B, C and D), 
there was a reduction in prevalence from 62 (25%) to 12 (5%) patients (p<0.05).
Conclusions: Bariatric surgery using the Roux-en-Y gastric bypass technique is 
effective in the control of reflux esophagitis. Regression is observed mainly in cases 
of moderate and severe esophagitis.
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Gastroesophageal reflux disease (GERD) is a multifactorial disease 
associated with environmental and genetic factors. Obesity is among the risk 
factors for its development, which also correlates with an increase in severity 
of clinical presentation and a higher incidence of complications associated 
with reflux1,2. Its prevalence distribution is quite variable in the world and 
depends on multiple factors, including eating behaviors, prevalence of obesity, 
smoking, and use of non-steroidal anti-inflammatory drugs3.
There are several mechanisms by which obesity interferes in the occurrence 
of GERD. Weight gain increases abdominal pressure and, consequently, 
intragastric pressure, besides promoting changes in the gastroesophageal 
pressure gradient. It also leads to changes in the integrity of the esophagogastric 
junction and cranial displacement of the lower esophageal sphincter (LES), 
with possible formation of hiatal hernia. Hiatal hernia is a known cause of 
GERD and is four times more common in obese people. Among the obese 
population there is also a higher prevalence of esophagitis, occurring more 
frequently in white patients when compared to black patients4-7. The aim of 
this study was to evaluate the impact of Roux-en-Y gastric bypass on the 
control of erosive esophagitis and metabolic and anthropometric parameters 
related to obesity.
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MATERIALS AND METHODS
This retrospective cohort study included 249 patients 
who underwent bariatric surgery using the Roux-en-Y 
gastric bypass technique at the Hospital São Vicente 
de Paulo (HSVP), southern Brazil, from January 
2014 to December 2015. The primary variables were 
analyzed in the preoperative and postoperative period 
between 6 and 12 months. Laboratory tests, upper 
digestive endoscopy, abdominal ultrasonography, 
anthropometric evaluation and body composition 
analysis by bioelectrical impedance were evaluated 
in order to analyze the impact of Roux-en-Y gastric 
bypass on reflux esophagitis. The secondary variables 
were weight loss, lean body mass increase, hepatic 
steatosis, level of high-density lipoprotein (HDL) 
cholesterol, level of low-density lipoprotein (LDL) 
cholesterol and total cholesterol.
Reflux esophagitis endoscopic evaluation was 
based on the Los Angeles Grading of Esophagitis 
as follows: grade A: mucosal break no longer than 
5 mm that does not extend between the tops of 
two mucosal folds; grade B: mucosal break longer 
than 5 mm long that does not extend between the 
tops of two mucosal folds; grade C: mucosal break 
that is continuous between the tops of two or more 
mucosal folds but involving less than 75% of the 
esophageal circumference; and grade D: mucosal 
break involving at least 75% of the esophageal 
circumference. Esophagitis improvement was 
determined by comparing Los Angeles Grading of 
Esophagitis grades on preoperative and postoperative 
upper digestive endoscopies.
Gastric bypass was performed with mechanical 
stapling, forming a gastric pouch with 30-mL 
capacity, a biliopancreatic limb length of 80 cm and 
an alimentary limb length of 100 cm. The diameter 
of the gastrojejunal anastomosis was 1.2 cm, and a 
Fouchet probe was used for calibration.
The data were entered into an Excel spreadsheet 
(Microsoft, United States). Statistical analysis was 
performed using SPSS statistical software, version 20.0. 
In all analyses, a p-value ≤ 0.05 was considered 
statistically significant. The qualitative variables 
were expressed as frequency and percentage, 
while the quantitative variables were expressed as 
mean ± standard deviation. The data were compared 
by the Pearson’s chi-square test.
RESULTS
Of the 242 patients in the study, 77.9% 
(190 patients) were female and the mean age was 
38 years. The mean body mass index (BMI) in the 
preoperative period was 41 kg/m3, total cholesterol 
was 207 mg/dL, LDL cholesterol was 118 mg/dL, 
HDL cholesterol was 49 mg/dL, fasting glucose 
was 105 mg/dL and hemoglobin was 13.9 g/dL. 
Bioelectrical impedance analysis showed a mean 
value of 55% of lean body mass and 58% of fat body 
mass. In the postoperative period, the mean BMI 
was 27.3 kg/m3, total cholesterol was 164 mg/dL, 
LDL cholesterol was 90 mg/dL, HDL cholesterol 
was 55 mg/dL, fasting glucose was 80 mg/dL and 
hemoglobin was 13 g/dL. Postoperative bioelectrical 
impedance analysis showed a mean value of 49% of 
lean body mass and 52% of fat body mass.
The occurrence of reflux esophagitis (Graph 1) in 
the preoperative period was 81.1% (196 patients), 
including 68.5% (134 patients) grade A, 26.9% 
(53 patients) grade B, 3.8% (7 patients) grade C and 
0.8% (2 patients) grade D. In the postoperative period, 
31.3% (75 patients) showed esophagitis, including 
84.6% (63 patients) grade A and 15.4% (12 patients) 
grade B, with no evidence of grade C or D. There was 
no difference regarding the distribution of esophagitis 
severity between female and male patients.
With regard to bariatric treatment response to control 
moderate and severe esophagitis (grades B, C and D), 
there was a reduction in prevalence from 25% (62 patients) 
to 5% (12 patients) (p<0.05). There was no statistically 
significant relationship between the percentage of 
weight loss or postoperative BMI and the occurrence 
of esophagitis, as well as between preoperative BMI 
and esophagitis severity.
Regarding secondary findings, the preoperative 
prevalence of hepatic steatosis was 78% (188 patients), 
whereas in the postoperative period 14% (34 patients) 
presented a mild degree of steatosis. Younger 
patients had higher levels of HDL cholesterol in the 
preoperative period (p<0.05), with no evidence of 
difference in the postoperative period. Higher plasma 
levels of HDL cholesterol in the preoperative period 
were related to a greater magnitude of weight loss 
Graph 1: Occurrence of reflux esophagitis in the preoperative 
and postoperative periods.
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(p<0.05). There was a positive correlation between 
reduced total cholesterol and increased lean body 
mass (p<0.05). Preoperative plasma levels of LDL 
cholesterol were higher among the male patients 
(p<0.05).
DISCUSSION
Esophagitis caused by GERD is a non-metabolic 
complication of obesity. The association between 
the two conditions is extremely relevant, with higher 
incidence of GERD in the obese population3 and 
higher recurrence rates of reflux disease in patients 
undergoing gastric fundoplication, mainly in those 
with a BMI greater than 35 kg/m2 8,9. Although sleeve 
gastrectomy is currently the most commonly performed 
bariatric surgery in the world, exceeding the number 
of Roux-en-Y gastric bypass procedures, the former 
is associated with poorer GERD-related parameters, 
especially reflux esophagitis10-12.
In this study, the incidence of reflux esophagitis 
before bariatric surgery was 81.1%, with variable 
degrees of esophagitis and with a high prevalence 
of moderate esophagitis. Gastric bypass was 
effective in the control of reflux esophagitis, being 
quite evident the regression in cases of moderate 
and severe esophagitis. An important improvement 
in GERD after bariatric treatment with the gastric 
bypass technique has been reported13-15, and the main 
mechanisms described to justify such improvement 
are the fact that the gastric pouch is small and has 
a lower acid production; weight loss leads to lower 
intra-abdominal pressure; and intestinal derivation 
improves biliary reflux. In this sample, no correlation 
was demonstrated between BMI – both preoperatively 
and postoperatively – and the degree of esophagitis.
The study also showed a significant improvement 
in metabolic parameters after bariatric treatment. 
There was a significant regression in the prevalence 
of hepatic steatosis and dyslipidemia. Serum HDL 
cholesterol levels in the preoperative period were 
associated with greater weight loss after bariatric 
surgery. In the postoperative period, serum glucose 
and LDL cholesterol levels reduced while HDL 
cholesterol levels increased, which is consistent with 
the finding of other studies16.
CONCLUSION
Bariatric surgery using the Roux-en-Y gastric 
bypass technique is effective in the control of reflux 
esophagitis. Regression is observed mainly in cases 
of moderate and severe esophagitis.
Roux-en-Y gastric bypass leads to a significant 
improvement in metabolic and anthropometric 
parameters, significantly reducing the plasma levels 
of LDL cholesterol and glucose as well as increasing 
HDL cholesterol. The postoperative reduction in BMI 
reveals that the technique can promote weight loss.
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